San Damiano, Italy

Lorena Fedeli

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorena Fedeli. Retrieved from https://idiyas.com/inventor/lorena-fedeli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorena Fedeli: Innovator in Taxane Production

Introduction

Lorena Fedeli is a notable inventor based in San Damiano, Italy. He has made significant contributions to the field of biotechnology, particularly in the production of taxanes, which are vital compounds in cancer treatment.

Latest Patents

Lorena Fedeli holds a patent for "Paclitaxel production by actinomycetes." This invention relates to microorganisms that produce taxanes, such as paclitaxel, and outlines the procedures for isolating these microorganisms from plants. The patent emphasizes the use of Actinomycetes group microorganisms, particularly those belonging to the genera Streptomyces, Actinoplanes, Nocardiopsis, Micromonospora, Actinomadura, and Kitasatosporia. A particularly preferred microorganism mentioned in the patent is Kitasatosporia sp. CECT 4991. He has 1 patent to his name.

Career Highlights

Lorena Fedeli is associated with Pharmacia & Upjohn, a company known for its advancements in pharmaceuticals. His work focuses on harnessing the potential of microorganisms for the production of essential medicinal compounds.

Collaborations

He has collaborated with notable coworkers, including Umberto Breme and Marinella Caruso, contributing to the advancement of research in his field.

Conclusion

Lorena Fedeli's innovative work in the production of taxanes showcases his commitment to advancing biotechnology and improving cancer treatment options. His contributions are significant in the realm of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…